Acellular mycobacterium smegmatis vaccine (Changchun Changsheng gene pharmaceutical)
无细胞耻垢分支杆菌疫苗（长春长生基因药业）
Report date: 2022/07/15 15:58:58
Base Information
Drug NameAcellular mycobacterium smegmatis vaccine (Changchun Changsheng gene pharmaceutical)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesChangchun Changsheng Gene Pharmaceutical Stock Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesChangchun Changsheng Gene Pharmaceutical Stock Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A